Back

Co-aggregation with Apolipoprotein E modulates the function of Amyloid-β in Alzheimer's disease

Xia, Z.; Prescott, E.; Leah, T.; Dakin, H.; Dimou, E.; Zuo, Y.; Zhang, Y. P.; Lam, J. Y. L.; Danial, J. S. H.; Jiang, H.; Mortiboys, H. J.; Thornton, P.; Crowther, D. C.; Holtzman, D. M.; Ranasinghe, R. T.; Klenerman, D.; De, S.

2021-07-14 neuroscience
10.1101/2021.07.13.452239 bioRxiv
Show abstract

Which isoforms of apolipoprotein E (apoE) we inherit determine our risk of developing late-onset Alzheimers Disease (AD), but the mechanism underlying this link is poorly understood. In particular, the relevance of direct interactions between apoE and amyloid-{beta} (A{beta}) remains controversial. Here, single-molecule imaging shows that all isoforms of apoE associate with A{beta} in the early stages of aggregation and then fall away as fibrillation happens. ApoE-A{beta} co-aggregates account for [~]50% of the mass of soluble A{beta} aggregates detected in the frontal cortices of homozygotes with the higher-risk APOE4 gene. Our results connect inherited APOE genotype with the risk of developing AD by demonstrating how, in an isoform- and lipidation-specific way, apoE modulates the aggregation, clearance and toxicity of A{beta}. Selectively removing non-lipidated apoE4-A{beta} co-aggregates enhances clearance of toxic A{beta} by glial cells, and reduces inflammation and membrane damage, demonstrating a clear path to AD therapeutics.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.